In a recent three-year period, more than 40% of active principal investigators in the United States conducted just one industry-sponsored pharmaceutical clinical trial, the authors of a forthcoming article for ACRP’s Clinical Researcher journal report.

We need to take a careful look at how best to evaluate, implement, and re-evaluate technology use at all stages of the trial and patient journey. This will inform a technology strategy to help leverage platforms to work for our site staff rather than against them.